Class IIOngoingD-0608-2025
Drug recall · September 10, 2025
Semaglutide recall
Why: Subpotent Drug
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
- Lots / codes
03202025@9 BUD 07/18/2025
- Quantity
- 186 vials
- Company
- Boothwyn Pharmacy LLC, Kennett Square, PA
- Distribution
- U.S. Nationwide
- Initiated
- July 9, 2025 · Voluntary: Firm initiated
- Classified
- August 29, 2025
- Reported
- September 10, 2025
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.